EP 3813822 A4 20220316 - SOLID ORAL PHARMACEUTICAL COMPOSITIONS COMPRISING TERIFLUNOMIDE
Title (en)
SOLID ORAL PHARMACEUTICAL COMPOSITIONS COMPRISING TERIFLUNOMIDE
Title (de)
FESTE ORALE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN MIT TERIFLUNOMID
Title (fr)
COMPOSITIONS PHARMACEUTIQUES SOLIDES D'ADMINISTRATION PAR VOIE ORALE COMPRENANT DU TÉRIFLUNOMIDE
Publication
Application
Priority
- TR 201809045 A 20180627
- TR 2019050497 W 20190624
Abstract (en)
[origin: WO2020005189A2] The present invention relates to pharmaceutical compositions comprising teriflunomide and one or more pharmaceutically acceptable excipient and are used in the treatment of autoimmune diseases such as especially systemic lupus erythematosus or chronic graft-versus-host disease, multiple sclerosis or rheumatoid arthritis.
IPC 8 full level
A61K 31/277 (2006.01); A61K 9/20 (2006.01); A61K 9/28 (2006.01); A61K 47/10 (2017.01)
CPC (source: EP)
A61K 9/2018 (2013.01); A61K 9/2059 (2013.01); A61K 31/277 (2013.01); A61P 25/28 (2017.12)
Citation (search report)
- [X] WO 2015077535 A2 20150528 - GENZYME CORP [US]
- [X] WO 2016189406 A1 20161201 - FTF PHARMA PRIVATE LTD [IN]
- [X] WO 2016079687 A1 20160526 - LUPIN LTD [IN]
- See references of WO 2020005189A2
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2020005189 A2 20200102; WO 2020005189 A3 20200312; EP 3813822 A2 20210505; EP 3813822 A4 20220316
DOCDB simple family (application)
TR 2019050497 W 20190624; EP 19824639 A 20190624